Zynex Medical Executives Indicted in $Millions Healthcare Fraud Scheme
A federal grand jury in Rhode Island has indicted two former executives of Zynex Medical, a pain management device company, on multiple counts of health care fraud. The indictment alleges a scheme to defraud insurers and patients spanning from 2017 through 2025.
Allegations of Fraud
Millions in Question
Former Chief Executive Officer Thomas Sandgaard and Chief Operating Officer Anna Lucsok are accused of fraudulently obtaining millions of dollars. These funds allegedly came from both government and commercial insurers, as well as directly from patients.
The indictment further alleges that Sandgaard and Lucsok misled investors. They reportedly concealed the fact that the company’s reported revenues were, in part, the result of fraudulent activity.
Official Response
United States Attorney Charles Calenda stated that the case “represents a troubling abuse of patients seeking care, as well as the federal healthcare benefit system.” This statement underscores the seriousness with which federal authorities are treating the allegations.
What Could Happen Next
Following the indictment, several scenarios are possible. The defendants could choose to contest the charges, leading to a trial. Alternatively, they may attempt to negotiate a plea agreement with the government. A conviction could result in substantial fines and imprisonment for both Sandgaard and Lucsok.
It is also possible that further investigations could be launched. These investigations could focus on other individuals or entities potentially involved in the alleged scheme. The government may also seek to recover the funds obtained through the alleged fraud.
Frequently Asked Questions
What specific types of fraud are alleged?
The indictment alleges that the former executives fraudulently secured millions of dollars from government and commercial insurers, as well as patients. It also alleges they defrauded investors by concealing the source of the company’s revenues.
Who are the individuals named in the indictment?
The indictment names Thomas Sandgaard, former Chief Executive Officer of Zynex Medical, and Anna Lucsok, former Chief Operating Officer.
What was the timeframe of the alleged fraudulent activity?
The alleged fraudulent activity occurred between 2017 and 2025, according to the indictment.
How might this case impact the pain management device industry and patient trust?